Prognostic Value of C-Reactive Protein in Adults With Tuberculous Meningitis: A Prospective Cohort Study

Lillian Tugume1, Fiona V Cresswell1,2,3, Nicole W Engen4

  • 1College of Health Sciences, Infectious Diseases Institute, Makerere University, Kampala  Uganda.

Insights

Elevated C-reactive protein (CRP) levels in adults with tuberculous meningitis (TBM), especially those with HIV, indicate a higher risk of poor outcomes. This inflammation marker can predict disease severity and prognosis in TBM patients.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Immunology

Background:

  • Tuberculous meningitis (TBM) is a severe infection with significant morbidity and mortality.
  • HIV co-infection is common in TBM cases, complicating diagnosis and treatment.
  • Predictive biomarkers for TBM prognosis are needed to guide clinical management.

Purpose of the Study:

  • To investigate the prognostic value of C-reactive protein (CRP) in adults with TBM.
  • To assess the association between baseline CRP levels and clinical outcomes at 8 weeks.

Main Methods:

  • A cohort of 135 adults with TBM was enrolled.
  • Baseline CRP levels were measured.
  • Modified Rankin Scale (mRS) scores were assessed at 8 weeks.
  • Statistical analysis was performed to determine the odds of poor outcomes based on CRP levels.

Main Results:

  • 83% of participants were living with HIV.
  • Participants with a baseline CRP ≥40 mg/L had significantly higher odds of an 8-week mRS score ≥4 (aOR, 2.78; 95% CI: 1.28-6.04; P = .010).
  • This association remained significant after adjustment for potential confounders.

Conclusions:

  • C-reactive protein (CRP) is a viable and accessible prognostic biomarker in tuberculous meningitis.
  • Elevated CRP levels at baseline can predict a worse clinical outcome in TBM patients.
  • CRP measurement may aid in identifying high-risk TBM patients requiring closer monitoring and intensified treatment.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
453
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
207
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
222
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
452